Document Detail


Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
MedLine Citation:
PMID:  2889528     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of 20 mg of famotidine or placebo on secretion of gastric juice and gastric acid were studied in ten healthy subjects in a randomized, crossover study. Gastric juice was aspirated and collected at hourly intervals for 24 hours after oral administration, and acid output was calculated based on gastric juice output and acid concentration. Secretion of gastric juice and acid output were lower after famotidine was administered than after placebo; over the 12-hour post-administration period, the hourly acid concentrations were significantly lower after famotidine than after placebo. During the 12 hours after famotidine or placebo, gastric juice output was 180.7 +/- 32.1 ml (mean +/- SE) in the placebo group and 64.7 +/- 9.1 ml in the famotidine group (P less than 0.01); acid concentrations were 49.3 +/- 3.8 mmol/L in the placebo group and 9.6 +/- 3.1 mmol/L in the famotidine group (P less than 0.01); acid output was 8.89 +/- 1.59 mmol in the placebo group and 0.55 +/- 0.17 mmol in the famotidine group (P less than 0.01). These results support the effectiveness of a 12 hour or possibly a 24-hour dosing interval for famotidine.
Authors:
Y Fukuda; I Ikezoe; M Okabayashi; I Ohama; T Shimoyama
Related Documents :
8944558 - Relation between gastric acid output, helicobacter pylori, and gastric metaplasia in th...
3148 - Prevention of experimental gastric ulcers in rats by dial derivatives.
7418588 - Inhibition of postprandial colonic motility after ingestion of an amino acid mixture.
6826108 - Effects of bombesin on gastrin and gastric acid secretion in patients with duodenal ulcer.
15766578 - Effect of a neutral citrate solution on the fluoride release of conventional restorativ...
23478338 - Rab12 regulates mtorc1 activity and autophagy through controlling the degradation of am...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Clinical therapeutics     Volume:  9     ISSN:  0149-2918     ISO Abbreviation:  Clin Ther     Publication Date:  1987  
Date Detail:
Created Date:  1987-12-17     Completed Date:  1987-12-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7706726     Medline TA:  Clin Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  528-35     Citation Subset:  IM    
Affiliation:
Hyogo College of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Famotidine
Gastric Acid / secretion*
Gastric Juice / secretion*
Histamine H2 Antagonists / pharmacology*
Humans
Male
Random Allocation
Thiazoles / pharmacology*
Chemical
Reg. No./Substance:
0/Histamine H2 Antagonists; 0/Thiazoles; 76824-35-6/Famotidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Distribution and biochemical characterization of somatostatin receptors in tumors of the human centr...
Next Document:  Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children.